The MIRD-226 mission is a collaborative effort between Russia's Roscosmos space agency and the Indian Space Research Organisation (ISRO). While the exact details of the mission were not widely disclosed, sources suggest that its primary objective is to demonstrate the feasibility of a joint Russian-Indian space station, with a focus on scientific research, technology development, and potential commercial applications.
Dysregulation of miR-226 has been implicated in several human diseases, including: mird-226
The MIRD-226 is a type of radioactive source used in nuclear medicine for therapeutic and diagnostic purposes. MIRD (Medical Internal Radiation Dose) is a committee that provides guidelines and recommendations for the use of radiopharmaceuticals in medicine. The MIRD-226 mission is a collaborative effort between